In addition, combination therapy in KRAS-driven lung tumors resulted in prominent induction of cellular senescence and infiltration of tumors with activated NK cells, which drove tumor cell clearance, and markedly increased survival in dual-treatment mice compared to single agent treated mice (Ruscetti et al., 2018). Here, KRAS is linked to neoplasm.